About Palivizumab
            
            Class: | Monoclonal antibody (anti-RSV)  
Use: | Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in high-risk pediatric patients  
Adult dose: | Not applicable; not indicated for adults  
Pediatric dose: | 15 mg/kg intramuscularly once a month during RSV season; typically administered for up to 5 months  
Side effects: | Common side effects include fever, rash, and injection site reactions (pain, erythema, swelling)  
Contraindications: | Hyperse
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (anti-RSV)
                 
                
                
                    
                        Uses & Indications
                    
                    Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in high-risk pediatric patients
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: AstraZeneca AB, SWEDEN
                    
                    
                    Package Size
                    1 Glass Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 4359.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Not applicable; not indicated for adults
                    
                    
                        Pediatric Dose
                    
                    
                        15 mg/kg intramuscularly once a month during RSV season; typically administered for up to 5 months
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include fever, rash, and injection site reactions (pain, erythema, swelling)
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to palivizumab or any component of the formulation; caution in patients with a history of severe allergic reactions
         
        
        
            
                Important Warnings
            
            Risk of serious hypersensitivity reactions; monitor for signs of anaphylaxis; not a substitute for RSV vaccination; use with caution in patients with bleeding disorders or thrombocytopenia
         
        
        
        
        
        
        
        
            
                Related Medicines in Same Category
            
            
                See also: Other Monoclonal antibody (anti-RSV) medicines available in UAE pharmacies
            
            
            
                Nirsevimab
            
            
            
                Nirsevimab
            
            
         
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.